4th Edition of International Conference on Probiotics and Prebiotics
March 26-28, 2026
Probiotics in Disease Prevention and Management
Probiotics in disease prevention and management offer a natural and effective approach to maintaining health and treating various conditions. They have been shown to help manage chronic diseases such as type 2 diabetes, by improving gut health and insulin sensitivity. Probiotics also play a key role in managing conditions related to the gut-brain axis, such as anxiety and depression, by modulating gut microbiota and influencing neurotransmitter production. Additionally, probiotics can be used to prevent antibiotic-associated diarrhea and restore balance to the microbiome after antibiotic treatments. Their therapeutic potential extends to preventing allergies, skin conditions, and even cardiovascular diseases, making probiotics an essential component in disease prevention and management strategies.
Dipak P Ramji
Cardiff University, United Kingdom
Jason Ryan
Sacco System, Australia
David Pineda Ereno
DPE International Consulting, Belgium
Thi Thu Hao Van
RMIT University, Australia
Yasin Ozdemir
Ataturk Horticultural Central Research Institute, Turkey
Esperanza Martinez Romero
Universidad Nacional Autonoma de Mexico, Mexico
Suriyavathana Muthukrishnan
Periyar University, IndiaSubmit your abstract Today
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India